Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacob Appelbaum

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Journal of the American Chemical Society|December 25, 2008
Selective recognition of protein tetraserine motifs with a cell-permeable, pro-fluorescent bis-boronic acidTiffany L Halo, Jacob Appelbaum, Elissa M Hobert, et al.
Blood Advances|November 1, 2021
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopeniaJacob Appelbaum, Donald M Arnold, John G Kelton, et al.
Expert Review of Hematology|February 23, 2019
Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapyUtkarsh H Acharya, Tejaswini Dhawale, Seongseok Yun, et al.
Leukemia|January 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, et al.
Journal for Immunotherapy of Cancer|September 2, 2018
Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case reportJacob Appelbaum, David Wells, Joseph B Hiatt, et al.
Leukemia|July 31, 2023
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasmsLauren Shih, Megan Othus, Kelda Schonhoff, et al.
Leukemia|November 26, 2022
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasmsGabrielle Paras, Megan Othus, Kelda Schonhoff, et al.
Transplantation and Cellular Therapy|November 5, 2025
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular TherapyHannah R Abrams, Helene Starks, Lindsey Bandini, et al.
Leukemia & Lymphoma|March 9, 2023
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agentsMichelle Y Zhang, Megan Othus, Carole Shaw, et al.
Research Square|October 27, 2023
Context-specific synthetic T cell promoters from assembled transcriptional elementsJacob Appelbaum, Jia Wei, Rithun Mukherjee, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Journal of the American Chemical Society|December 25, 2008
Selective recognition of protein tetraserine motifs with a cell-permeable, pro-fluorescent bis-boronic acidTiffany L Halo, Jacob Appelbaum, Elissa M Hobert, et al.
Blood Advances|November 1, 2021
SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopeniaJacob Appelbaum, Donald M Arnold, John G Kelton, et al.
Expert Review of Hematology|February 23, 2019
Management of cytokine release syndrome and neurotoxicity in chimeric antigen receptor (CAR) T cell therapyUtkarsh H Acharya, Tejaswini Dhawale, Seongseok Yun, et al.
Leukemia|January 27, 2025
Probability of remission with reinduction with 7+3 versus high-dose cytarabine: analysis of SWOG trial S1203Megan Othus, Guillermo Garcia-Manero, Frederick R Appelbaum, et al.
Journal for Immunotherapy of Cancer|September 2, 2018
Fatal enteric plexus neuropathy after one dose of ipilimumab plus nivolumab: a case reportJacob Appelbaum, David Wells, Joseph B Hiatt, et al.
Leukemia|July 31, 2023
Comparison between measurable residual disease relapse and morphologic relapse in acute myeloid leukemia and high-grade myeloid neoplasmsLauren Shih, Megan Othus, Kelda Schonhoff, et al.
Leukemia|November 26, 2022
Effect of ECOG performance status on outcomes in patients with acute myeloid leukemia and other high-grade myeloid neoplasmsGabrielle Paras, Megan Othus, Kelda Schonhoff, et al.
Transplantation and Cellular Therapy|November 5, 2025
National Landscape of Logistical and Nonmedical Requirements for Transplantation and Cellular TherapyHannah R Abrams, Helene Starks, Lindsey Bandini, et al.
Leukemia & Lymphoma|March 9, 2023
Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agentsMichelle Y Zhang, Megan Othus, Carole Shaw, et al.
Research Square|October 27, 2023
Context-specific synthetic T cell promoters from assembled transcriptional elementsJacob Appelbaum, Jia Wei, Rithun Mukherjee, et al.
Pageof 2